Glutamate decarboxylase (GAD) is an enzyme that synthesizes -aminobutyrate (GABA), a major inhibitory neurotransmitter in the central nervous system. Post-translational modification of GAD, such as Nterminal blockage, phosphorylation-dephosphorylation, and palmitoylation, is an important factor in the biological activity of GAD. In order to address the significance of post-translational events on GAD, we thought it crucial to obtain a non-recombinant form of GAD. In this study, we attempted to isolate GAD protein from the monkey brain, a model animal close to the human that has not been studied. Monkey brain was homogenized, fractionated with ammonium sulphate, and applied to a series of chromatographic steps, including hydrophobic, ion-exchange, and gel filtration. Purified GAD showed a single band on SDS-PAGE, and the enzyme was found to have a molecular weight of 61,000 and exhibited 1,100 nmol/min/mg of specific activity. It had an optimal pH of 7 and optimal thermal stability at 40 C.
-Aminobutyrate (GABA) is an inhibitory neurotransmitter in the central nervous system of higher animals, 1, 2) and is also known to exhibit other biological activities, such as lowering of high blood pressure 3) and diuretic action. 4) It is synthesized by L-glutamate decarboxylase (E C 4. 1. 1. 15, GAD) which catalyzes a one-step decarboxylation reaction of L-glutamate. 5, 6) GAD requires pyridoxal phosphate (PLP) as a coenzyme, where PLP forms an internal Schiff base with an active site lysine residue. In mammals, GAD is highly localized in neuronal systems, the brain, 7) the pancreas, 8) liver, 9) and germ cells. 10) GAD activity in other tissues is low and was considered insignificant, but recent studies of the specific localization of GAD in taste buds, 11) stomach, intestine, 12) and skin 13) suggest that it plays important biological roles in those tissues, which must be investigated. There have been many attempts to purify mammalian GADs, [14] [15] [16] but the cDNA of GAD has been reported 17) and the discovery of GAD isoforms in 1990 by Tobin's group 18) indicated that earlier purification attempts did not discriminate the isoforms. 6) It is now clear that mammals have two isoforms, GAD65 and GAD67, that can be co-expressed in the same cells but have different functions. 18, 19) For example, GAD65 is located at the neuronal terminal, where it is involved in the synthesis of GABA and the packaging of GABA molecules into vesicles. 20, 21) GAD67 exists in the cytosol and plays important metabolic roles. 22, 23) In principle, GAD isoforms differ in their cellular distribution, 24) physiological roles, affinity to the coenzyme PLP, 25) and activity regulation by phosphorylation. 26) In recent studies on GAD, recombinant GADs expressed in S. cerevisiae 27) and E. coli 28, 29) have been used. The recombinant enzymes are particularly useful in X-ray crystal studies, 30) where Lys405 is located at the active site and Glu190, Ser192, and Arg567 are involved in substrate binding. 30) However, studies using recombinant enzymes cannot provide information on physiological roles that involve post-translational modifications, since the recombinant enzymes cannot reproduce these modifications. Post-translational modification of GAD is localized in the N-terminal regions: viz., blockage of the N-terminal amino group, palmitoylation, 31, 32) and phosphorylation. 33) Hence it is highly desirable to obtain non-recombinant GAD protein for analysis of post-translational modifications.
The monkey is used as an experimental animal due to its similarity to humans. The genome of the monkey has been analyzed as the third primate case, 34) and monkey genome coincides 97.5% with the human.
35) The monkey gene for GAD65 is located at ch9 26475678-26475880, and has 16 exons (2281 bp) that encode for a 540-amino-acid protein. The GAD67 gene, located on ch12 34544262-34544370, has 17 exons (3,581 bp) that encode for a 594-amino-acid protein (Table 1) . Unlike GADs from other laboratory animals like rat and mouse, monkey GAD has not been studied extensively. In this study, we attempted to obtain a sufficient quantity of purified GAD from monkey brain to investigate further the biochemistry of the enzyme in relation to post-translational modifications that are important to its physiological roles.
Materials and Methods
Chemicals. All chemicals used in this study were purchased from distributors at the highest purity available. HEPES, benzamidine HCl, DTT, PLP, and PMSF were from Wako (Saitama, Japan). AET and EDTA were from Nacalai Tesque (Tokyo). Triton X-100 was from Polyscience (Warrinton, USA), and protease inhibitor cocktail was from Roche (Basel, Switzerland). Phenyl-TSK (C) and DEAE-TSK (S) were purchased from Tosoh (Yamaguchi, Japan). Superdex-200 was purchased from GE-Pharmacia (Tokyo). PVDF membrane was from BioRad (Richmond, USA).
Animals and tissue processing. Male monkeys (Macaca fuscata) weighing 4-5 kg were obtained from a local supplier (Keari, Osaka). The animals were kept in accordance with institutional guidelines (Animal Research Laboratory, Osaka Medical College). After administration of a lethal dose of pentobarbital, the brain was removed, immediately frozen in liquid nitrogen, and stored at À80 C until use.
Enzyme assay. An assay mixture containing 20 mM L-glutamate, 0.2 mM PLP, and 50 mM HEPES buffer, pH 7.0, and a solution containing the enzyme, were made up to a final volume of 1 ml. The reaction was initiated by adding the enzyme solution, incubated at 37 C for 1 h, and was terminated by adding 0.04 ml of 60% perchlorate. The GABA formed during incubation was separated from L-glutamate on a strong cation exchange column, as used in amino acid analysis, 36, 37) and was quantitated by derivatization with o-phthalaldehyde. 38 ) GAD activity was defined as an amount of GABA produced per min of incubation at 37 C.
Protein estimation. The protein concentration was estimated by the Bradford method, 39) and bovine serum albumin (BSA) was used as the standard.
Pirification of GAD. Ten g of monkey brain was suspended in 3 volumes of 50 mM HEPES buffer, pH 7.0, containing 1 mM each of AET, benzamidine HCl, DTT, and EDTA and 0.1 mM each of PMSF and PLP, and 0.1% Triton-X 100, followed by disruption with a tissue homogenizer 6 times in a cycle of 20 s of homogenization and 40 s of cooling. The homogenate was centrifuged at 9;000 Â g for 60 min. The resulting supernatant was used as crude extract. All purification steps were carried out at 4 C. Crude extract was brought to 60% saturation with solid ammonium sulphate. The solution was stirred gently for 60 min until solid ammonium sulphate was completely dissolved, and then it was centrifuged at 9;000 Â g for 60 min. The pellet was collected and dissolved in about twice the volume of 10 mM potassium phosphate buffer, pH 7.0, containing 1 mM each of AET, benzamidine HCl, DTT, and EDTA, and 0.1 mM each of PMSF and PLP and 40 ml/ml of protease inhibitor cocktail.
After ammonium sulphate precipitation, the dissolved solution was applied to a Phenyl-TSK column (1:0 Â 12 cm), which was equilibrated with 10 mM sodium phosphate buffer, pH 7.0, containing 2 M NaCl and 1 mM each of AET, benzamidine HCl, DTT, and EDTA, and 0.1 mM each of PMSF and PLP. The column was washed with the equilibration buffer, and then the enzyme was eluted with 30 ml of water containing 1 mM each of AET, benzamidine HCl, DTT, and EDTA, and 0.1 mM each of PMSF and PLP. Fractions containing GAD activity were pooled and concentrated to about 5 ml by Amicon YM-10 ultrafiltration, and were dialyzed against 1 mM potassium phosphate buffer, pH 7.4, containing 1 mM each of AET, benzamidine HCl, DTT, and EDTA and 0.1 mM each of PMSF and PLP. The enzyme fraction from the previous step was applied to a DEAE-TSK column (1:0 Â 5:5 cm) equilibrated with 10 mM potassium phosphate buffer, pH 7.0, containing 1 mM each of AET, benzamidine HCl, DTT, and EDTA and 0.1 mM each of PMSF and PLP. The column was washed with the same buffer, and then the enzyme was eluted with a linear gradient of 0 to 0.5 M NaCl. Fractions containing GAD activity were pooled and concentrated by Amicon YM-10 ultrafiltration. The enzyme fraction from the previous step was applied to a Superdex-200 column (1:6 Â 50 cm) equilibrated with 50 mM potassium phosphate buffer, pH 7.0, containing 150 mM NaCl, and then the enzyme was eluted with the same buffer. Fractions containing GAD activity were pooled and concentrated by Amicon YM-10 ultrafiltration.
SDS-PAGE analysis. SDS-PAGE analysis of protein samples was carried out as described by Laemmli. 40) The samples were mixed with a sample buffer including 1% SDS and 5% 2-mercaptoethanol at the ratio of 4:1, and boiled for 10 min. Slab gel containing 10% polyacrylamide was used in electrophoresis, which was carried out at 200 V for 35 min. After electrophoresis, the gels were stained with 0.1% CBB-R250 for 15 min, then destained and dried under a vacuum on a BioRad gel dryer model 543. The molecular weight of the unknown protein sample was estimated by comparing it with standard proteins for migration lengths. A BioRad low-range marker was used as the molecular marker.
Western blot analysis. SDS-PAGE gel was electrically blotted onto a PVDF membrane at 15 V for 60 min on a BioRad semi-dry blotter. After blotting, the membrane was soaked in 5% skim milk at room temperature for 60 min. Then rabbit anti-GAD65/67 polyclonal antibody (Sigma, no. G-5163) at 10;000Â dilution with antibody buffer as described in the supplier's manual, was used as the primary antibody. The membrane and antibody solution were placed into a plastic bag, which was then heat-sealed and incubated at room temperature for 2 h. The membrane was washed with Tris buffered saline with Tween 20 (TTBS) and placed in a plastic bag, to which donkey anti-rabbit IgG antibody with HRP (Amersham) at a dilution of 10;000Â with antibody buffer was added as a secondary antibody. The membrane was incubated at room temperature for 1 h, washed with TTBS, and supplemented with ECL detection reagent (Amersham). Chemiluminescence was exposed to Polaroid film with an Amersham filming apparatus. We also used mouse anti-GAD6 antibody as primary antibody, then donkey anti-mouse IgG antibody was used as secondary antibody.
Results

Purification of GAD
The tissue homogenate was applied to ammonium sulphate precipitation in a range of 10-80%. The highest activity was recovered at 60% precipitation (data not shown), at which the yield of protein recovery was 45%.
Western blot analysis with anti-GAD65/65 antibody indicated that precipitation in a range of 40-80% contained GAD protein (data not shown). Above 70% ammonium sulphate treatment, lipid components coprecipitated, severe tailing in SDS-PAGE was evident, and the GAD activity in these fractions was quite low. Hence, we employed 60% precipitation. GAD was eluted in the water fraction. When water was used as the eluent and GAD activity was eluted off for 10-40 min. The yield of activity was 8.9% (Table 1) . When 50% ethyleneglycol in water was used as the eluent, no more GAD activity was eluted off (data not shown). As shown in Fig. 1A , GAD activity was eluted off in a range of 0.2-0.3 M NaCl. Each of the fractions was analyzed by Western blot (Fig. 1B) . Activity recovery was 31% and specific activity increased 1.1-fold from the previous step. When gel filtration was carried out on Superdex-200 for DEAE-TSK purified fractions, GAD activity was eluted at about 155-190 min ( Fig. 2A) . SDS-PAGE analysis showed two separate protein populations, distinguished by the molecular sizes for proteins eluted A B at 155-165 min and 180-190 min (Fig. 2B) . The fractions corresponding to 155-165 min and 180-190 min were pooled. Both fractions exhibited GAD activity and positive bands for anti-GAD antibody on Western blot (Fig. 3B) . Fraction 1 appeared to be GAD protein of the expected molecular size. About 120-fold purification was achieved for fraction 1. As shown in Fig. 3A -C, lane 5 for fraction 1 gave a 63-kDa protein band on both CBB stain and Western blot, but lane 6 for fraction 2 gave 63 kDa only on Western blot. Fraction 2 contained significant amounts of other proteins, as indicated by the 32-kDa and 29-kDa bands on CBB stain and by the 95-kDa band on Western blot. These proteins were not analyzed in this study.
Optimal conditions
Part of the purified GAD was used to determine the optimal temperature and pH for enzyme activity. The pH of the assay mixture was adjusted with HCl or NaOH. Incubation was carried out for 30 min in 50 mM HEPES buffer including 20 mM L-glutamate and 0.2 mM PLP and enzyme activity was plotted against various temperatures (A) and pHs (B) (Fig. 4) . The profiles showed the optimum temperature and pH to be at about 40 C and 7.0.
Effect of amino acids on GAD activity
The effects of glutarate, L-Asp, D-Glu, L-Asn, and L-Gln, present during the GAD activity assay, were examined individually. The concentration of the exam- The fraction from DEAE-TKS was applied to a Superdex-200 column. The column was equilibrated with 50 mM potassium phosphate buffer, pH 7.0, containing 150 mM NaCl, and protein elution was carried out with the same buffer. A, Elution profile; The solid line is an absorbance monitor at 280 nm, and the open circle indicates GAD activity. Numbers correspond to the lane numbers appearing in Fig. 2B . B, SDS-PAGE results. Lane 1 is the DEAE-TSK fraction, and lanes 2 through 13 correspond the fractions numbered in Fig. 2A. A B C Fig. 3 . SDS-PAGE and Western Blot Analysis of Monkey Brain GAD. A, CBB-stain; B, Western blot with anti-rat GAD65/67 antibody; C, Western blot with GAD6 monoclonal antibody. The enzyme samples were boiled for 10 min in the presence of 1% SDS and 5% 2-mercaptoethanol, and applied to a 10% polyacrylamide gel, and electrophoresis was done with 25 mM Tris/192 mM glycine running buffer. For SDS-PAGE, the gel was stained with CBB. Western blot was carried out with rabbit anti-GAD65/67 antibody (Sigma G-5163) as the primary antibody and HRP-conjugated donkey anti-rabbit IgG antibody as the secondary antibody. For C, GAD6 monoclonal antibody was used. ined amino acid was 1 mM. Glutarate, L-Asp, and D-Glu reduced GAD activity to 42, 20, and 25% respectively. Much less effect was observed for L-Asn and L-Gln, as they reduced GAD activity to 4% and raised it to 18%, respectively (Fig. 5) .
Discussion
GABA-synthetic enzyme, GAD, showed intriguing profiles of post-translational modification when Nterminal amino acid blockage, palmitoylation, phosphorylation-dephosphorylation, and interaction with other proteins 31, 33, 41) took place. Unfortunately, none of these profiles was extensively studied due to a lack of purified protein from tissue specimens.
A majority of studies nowadays utilize recombinant enzymes that are expressed in E. coli, yeast, or tissuecultured cells. These recombinant enzymes are not suitable for the study of post-translational events. To obtain GAD suitable for post-translational studies, we carried out purification of GAD from monkey brain. Table 1 summarizes the overall purification steps for GAD starting from 10 g of monkey brain. We employed five steps to obtain apparent homogeneity on SDS-PAGE and subsequent Western blot analysis, and achieved 550-fold purification.
Ammonium sulphate precipitation
Ammonium sulphate precipitation is a common technique of enzyme purification. Previous studies employed 25-65% ammonium sulphate fractionation as the first step in GAD purification. 15) In our experiment, one-step precipitation of 60% ammonium sulphate appeared to be most effective to obtain the highest enzyme activity.
Phenyl-TSK chromatography
Hydrophobic chromatography is a relatively new technique that figures in purification methods. Among the hydrophobic resins phenyl, butyl, and ether, phenyl is the weakest. Previous studies using phenyl resin in GAD purification showed a tendency to raise the specific activity in a range from 3-to 13-fold with fair recovery, at around 36%. 22, 42) Under our experimental conditions, GAD was absorbed by phenyl-TSK resin and eluted by water because none of the buffer solutions eluted GAD from the resin. Even eluting with water, a fair amount of water was required for elution. The recovery of GAD activity was 36%, and the activity decreased 13% after storage at 4 C for 5 d. We suspect that the removal of protein molecules from GAD-protein complex may have caused instability after phenyl-TSK purification. Hence, we examined our hypothesis by adding BSA. The addition of BSA improved enzymatic activity (data not shown), but we omitted adding extra BSA because it might complicated the purification steps. GAD activity was measured under standard assay conditions. The concentration of each amino acid was 1 mM.
DEAE-TSK chromatography
Chromatographic separation on DEAE-TSK was carried out for the fractions from phenyl-TSK column chromatography. Since water was used as the eluent in phenyl-TSK chromatography, there was no need to perform an extra dialysis step to remove salt. The result of DEAE-TSK separation was that GAD was eluted in 0.2-0.3 M NaCl fractions, where the peak of A 280 closely corresponded with the peak of GAD activity. The DEAE-TSK chromatographic step was useful, since it provided nearly a single band on SDS-PAGE, although the specific activity did not improve as expected. The enzyme after chromatography was still unstable, and the activity fell to 40% after 5 d of storage at 4 C. As judged by Western blot analysis, the peaks corresponding to GAD were degraded even when a buffer containing a mixture of protease inhibitors was used.
Previous studies have indicated that the yield of GAD activity after DEAE-cellulose chromatography was in a range of 15 to 50%, where about 5-fold purification was achieved. 14, 43, 44) When DEAE-Sepharose resin was used, the yield was 70% and purification was 4-fold. 45 ) When DEAE-Sephacel was used, about 70 to 80% yield and 4-to 6-fold purification were achieved. 22, 42) Our present data on DEAE-TSK, which is made of hydrophilic vinyl polymer-based material, gave results comparable to DEAE-cellulose, but a lower yield than other resins. The lower yield of activity might have been due to the removal of the protein component that complexed with GAD. We will make further attempts to improve stability.
Gel filtration purification
Superdex gel filtration chromatography gave two peaks containing GAD activity. SDS-PAGE analysis for each of the fractions showed that the first peak fraction gave a 66-kDa protein band, while no corresponding bands were observed for the second one. However, the Western blot analysis gave a 66-kDa protein band for both fractions. The reason for the two GAD peaks on Superdex gel filtration chromatograpy must be investigated. In previous attempts to purify other mammalian GADs, the use of Sephadex resin gave 50% yield. 14, 44) Molecular weights ranging from 40,000 to 80,000 were also reported. 18, 46) As for this inconsistency as to GAD size, it is speculated that some sort of post-translational modification may be involved.
We used G-5163 (Sigma) antibody as the primary antibody since it is highly specific to the C-terminal region of GAD, where the sequence is indistinguishable between GAD65 and GAD67 for human, rat, and mouse. On the other hand, the monkey genome indicates that monkey GAD65 lacks the epitope sequence recognized by G-5163 antibody, which suggests that we should be able to isolate the GAD67 form from the monkey brain. Hence we expected that the GAD we purified was GAD67, but when monoclonal antibody, GAD6, was used, it recognized the protein band at 66 kDa (Fig. 3C ).
Since GAD6 is specific to GAD65, 47) there is a possibility that GAD65 was present in our isolated fractions. We intend to clarify this point in future study.
Optimal conditions
We determined the optimal temperature and pH for the purified enzyme. A flat optimal temperature range at about 37-50 C (Fig. 4A ) and a pH optimum in a range of 7.0-8.0 (Fig. 4B) were observed. Previous investigators have reported that pH optimum for mouse brain enzyme was 7.0, 15) but little study has done on temperature stability.
Amino acids affecting GAD activity
We examined the effects of glutarate, L-Asp, D-Glu, L-Asn, and L-Gln on purified GAD for the stability and activity of the enzyme. As shown in Fig. 5 , the presence of 1 mM glutarate, L-Asp, and D-Glu inhibited 50, 20, and 30% of GAD activity respectively. L-Asn did not have any effect on GAD activity, whereas L-Gln showed a slight increase in activity. Our present results agree with previous findings that glutarate and Asp are inhibitors of brain GAD. 48, 49) Inhibition of glutarate was also found for E. coli enzyme, where the mode of inhibition was competitive with L-Glu. 50, 51) L-Gln raised the activity. A study by Battaglioli and Martin showed the similar results for L-Gln tested on brain slices. 52) In this study, we purified GAD protein to near homogeneity from the monkey brain with an overall yield comparable to GADs from other animal sources. The temperature and pH stabilities as well as the inhibition profiles for our purified enzyme from the monkey brain resemble those from other animal sources. The properties of monkey brain GAD are identical to those from other animal sources. To this extent, the monkey brain may have some advantages over other animal sources because of the brain size which gives large quantities of GAD protein per purification step. We intend to investigate problems such as N-terminal blockage and phosphorylation-dephosphorylation on monkey brain GAD.
